Life Sciences Regulation in Finland: Overview

Thomson Reuters Practical Law Life Sciences Global Guide 2023

Posted on

11 Jul

2023

Dittmar & Indrenius > Insight > Life Sciences Regulation in Finland: Overview

A Q&A guide to life sciences regulation in Finland.

This Q&A provides a high-level overview of key practical issues, including life sciences clinical trials, manufacturing, marketing, abridged procedure, pharmacovigilance, data privacy, packaging and labelling, biological medicines, medical devices, health care IT, combination products, borderlines, and natural health products.

Read the Finland chapter we contributed: Life Sciences Regulation in Finland: Overview

Read also: Life Sciences Commercialisation in Finland: Overview

Written by

Charlotta Bonsdorff

Senior Associate

Juli Mansnérus

Partner
+358 44 272 4727
Linkedin

Inari Paila

Senior Attorney
+358 50 388 9591
Linkedin

Roope Fredman

Associate
+358 50 410 0605
Linkedin

Service areas

Related

Q&A - Navigating the future of health lawAs the healthcare landscape undergoes unprecedented transformation driven by AI, personalised m...
Finnish NIS2 requirements are now in force - Key InsightsFinland has finally implemented the EU Directive on Measures for a High Common Level of Cyberse...
DORA Is Now Applicable - Key Implications for ICT Service ProvidersEU’s Digital Operational Resilience Act (2022/2554, “DORA”) became applicable...

More by the same author

Q&A – Navigating the future of health law

As the healthcare landscape undergoes unprecedented transformation driven by AI, personalised medicine, and evolving regulatory frameworks, the legal challenges facing the life sciences sector have never been more complex or consequential.

Reform of the Act on the Secondary Use of Social and Health Data

The Act on the Secondary Use of Social and Health Data (552/2019) is being reformed The Act on the Secondary Use of Social and Health Data (552/2019) (the “Secondary Use Act”), which lays out rules on the use of social and health data in Finland for secondary purposes, entered into force in May 2019. Secondary use of social and health data refers to the use of such data for statistics, scientific research, development and innovation, education, policy-making and regulatory activities by public authorities.

Government proposal regarding the implementation of EU’s NIS 2 Directive published

On 23 May 2024, the Finnish Government submitted its proposal regarding the implementation of EU’s NIS 2 Directive ((EU) 2022/2555, the “Directive”) to the Parliament. The proposal includes, inter alia, the adoption of the new Cybersecurity Act and amendments to the Act on Information Management in Public Administration and the Act on Electronic Communications Services. The objective is that the proposed legislation would enter into force on 18 October 2024.

Latest insights

Data Act is applicable in all EU Member States

Article / 12 Sep 2025

Q&A - Navigating the future of health law

Article / 25 Aug 2025